We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-14.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.1B
AUM Growth
-$2.86B
Cap. Flow
-$262M
Cap. Flow %
-2%
Top 10 Hldgs %
37.9%
Holding
1,479
New
56
Increased
646
Reduced
399
Closed
58

Sector Composition

Rank Sector Weight
1 Real Estate 60.75%
2 Technology 8.8%
3 Healthcare 4.18%
4 Consumer Discretionary 3.61%
5 Financials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCPH
1176
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$3K ﹤0.01%
199
NGM
1177
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$3K ﹤0.01%
265
IMGN
1178
DELISTED
Immunogen Inc
IMGN
$3K ﹤0.01%
693
RETA
1179
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$3K ﹤0.01%
108
ACET icon
1180
Adicet Bio
ACET
$74M
$2K ﹤0.01%
7
ALT icon
1181
Altimmune
ALT
$607M
$2K ﹤0.01%
136
AMRN
1182
Amarin Corp
AMRN
$291M
$2K ﹤0.01%
67
ANAB icon
1183
AnaptysBio
ANAB
$1.57B
$2K ﹤0.01%
105
+45
+75% +$997
AQN icon
1184
Algonquin Power & Utilities
AQN
$4.74B
$2K ﹤0.01%
+500
New +$7.24K
ATAI icon
1185
AtaiBeckley Inc
ATAI
$2.65B
$2K ﹤0.01%
468
AVIR icon
1186
Atea Pharmaceuticals
AVIR
$373M
$2K ﹤0.01%
242
AVXL icon
1187
Anavex Life Sciences
AVXL
$232M
$2K ﹤0.01%
222
BAND
1188
CALL
Bandwidth Inc
BAND
$1.77B
$2K ﹤0.01%
50
CDXS icon
1189
Codexis
CDXS
$136M
$2K ﹤0.01%
189
CGEM icon
1190
Cullinan Oncology
CGEM
$1.06B
$2K ﹤0.01%
127
CHRS icon
1191
Coherus Oncology
CHRS
$222M
$2K ﹤0.01%
262
COLL icon
1192
Collegium Pharmaceutical
COLL
$1.16B
$2K ﹤0.01%
127
+51
+67% +$858
CSTL icon
1193
Castle Biosciences
CSTL
$740M
$2K ﹤0.01%
86
DSGN icon
1194
Design Therapeutics
DSGN
$728M
$2K ﹤0.01%
162
EDIT icon
1195
Editas Medicine
EDIT
$396M
$2K ﹤0.01%
200
EOLS icon
1196
Evolus
EOLS
$414M
$2K ﹤0.01%
162
ERAS icon
1197
Erasca
ERAS
$6.36B
$2K ﹤0.01%
354
GEN icon
1198
PUT
Gen Digital
GEN
$16.3B
$2K ﹤0.01%
2,000
GERN icon
1199
Geron
GERN
$924M
$2K ﹤0.01%
1,407
+723
+106% +$1.02K
GOSS icon
1200
Gossamer Bio
GOSS
$110M
$2K ﹤0.01%
260

Similar funds

Daiwa Securities Group's Q2 2022 Portfolio in Review

As of Q2 2022, Daiwa Securities Group held 1,479 positions worth $13.1B, down 18% from $16B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q2 2022 filing shows 56 new, 646 increased, 399 reduced and 58 closed positions. Its largest new stake was HDFC Bank: 143,030 shares worth $3.93M. The largest sale was American Tower, an estimated $263M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 60% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q2 2022 buy was HDFC Bank: 143,030 shares worth $3.93M.
  • Daiwa Securities Group added most to Mid-America Apartment Communities in Q2 2022, an estimated $174M increase.
  • Daiwa Securities Group's biggest Q2 2022 reduction was American Tower, cutting an estimated $263M.
  • Daiwa Securities Group fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $7.68M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13.1B portfolio in Q2 2022.
  • Daiwa Securities Group opened 56 new positions and closed 58 in Q2 2022.
  • Daiwa Securities Group's portfolio value fell 18% quarter-over-quarter to $13.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2022, filed 9 Aug 2022.